Skip to content

PUL vs TURP in BPH Patients With Urinary Retention

Prostatic Urethral Lift Versus Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients With Urinary Retention

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06037356
Acronym
PULTUR
Enrollment
100
Registered
2023-09-14
Start date
2025-01-01
Completion date
2035-05-30
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPH With Urinary Obstruction

Keywords

BPH, Urinary retention, prostatic urethral lift, PUL, TURP

Brief summary

The study will be a prospective, randomized controlled trial comparing prostatic urethral lift (PUL) versus transurethral resection of prostate (TURP) in benign prostate hyperplasia (BPH) patients with urinary retention. The primary objective of this study is to compare the catheter-free rates of PUL vs TURP. Secondary objectives include comparison of complications rates, cost effectiveness, patient satisfactory, symptom scores, quality of life measures and urodynamic parameters.

Detailed description

The study will be a prospective, non-inferiority randomized controlled trial with the aim of detecting a non-inferiority margin of 5%. After the potential subject has been informed of the study and the potential risks, he will be screened for eligibility within a 4 week period. Assessment of eligibility will include questionnaires, blood tests, urine tests, uroflowmetry, flexible cystoscopy, transrectal ultrasound, and urodynamic study. Suitable subjects will then be randomized in a 1:1 ratio to the prostatic urethral lift (intervention group) and TURP (control group). Patients in the prostatic urethral lift will have the procedure performed under local anesthesia or monitored anesthetic care while TURP patients will be performed under spinal or general anesthesia. The subjects will have regular follow up 1 month, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years post-operatively. Follow up assessments will include questionnaires, uroflowmetry, and occasional urodynamic study.

Interventions

DEVICEProstatic Urethral Lift

Prostatic urethral lift uses permanent implants to retract the prostate lobes away from the prostate urethra to allow unobstructed passage of urine. These implants are made of Nitinol, non-absorbable monofilament suture material (Poly Ethylene Terephthalate), Stainless Steel

PROCEDURETURP

Using monopolar or bipolar loop diathermy via cystoscopy, excess prostate tissue is resected piecemeal to remove obstruction to the prostatic urethra due to BPH

Sponsors

Queen Mary Hospital, Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study will be a prospective, non-inferiority randomized controlled trial with the aim of detecting a non-inferiority margin of 5%. Subjects will be randomized in a 1:1 ratio.

Eligibility

Sex/Gender
MALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male patients * age \>40 years old * urinary retention who failed trial without catheter

Exclusion criteria

* Inability to provide consent OR no guardians or relatives to help provide consent on patient's behalf * Active urinary tract infection * Previous surgical treatment for benign prostatic hyperplasia (i.e., TURP, prostatic urethral lift, etc.) * Bladder stones * Urethral strictures or bladder neck contractures * Prostate size \>100mL * Solely obstructing median lobe * Urinary retention not due to obstruction (i.e., Bladder outflow obstruction index \<20 on urodynamic studies) * Poor detrusor contractility (maximum detrusor pressure \<20cmH2O during voiding phase) * Anticoagulant or antiplatelet agents that cannot be stopped

Design outcomes

Primary

MeasureTime frameDescription
Catheter-free rates after prostatic urethral lift versus TURP in BPH patients with urinary retention1 year after interventionTo determine how many patients will be catheter-free (defined as by the ability to void with a post-void residual urine \<300mL) after intervention and remain catheter-free at 1 month, 3 months, and 1 year after intervention

Secondary

MeasureTime frameDescription
Cost effectiveness of prostatic urethral lift versus TURP in achieving catheter-free rates in BPH patients with urinary retention1 yearTo determine the cost required to achieve catheter free patients for each intervention (including hospitalization, anesthetic costs, equipment, consumables, etc)
Compare patient satisfaction by PGI-I questionnaire after prostatic urethral lift versus TURP1 yearUsing the Patient global impression of improvement (PGI-I) questionnaire to determine patient satisfaction after each intervention. * minimum score is 1, maximum score is 7 * higher score means worse outcome
Compare patient reported symptom measures by IPSS questionnaire after prostatic urethral lift versus TURP1 yearUsing International prostate symptom score (IPSS) questionnaire to determine patient reported symptom measure after each intervention * minimal score: 0, maximum score is 35 * higher score means worse outcome
Compare patient reported symptom measures by ISI questionnaire after prostatic urethral lift versus TURP1 yearUsing the Incontinence severity index (ISI) questionnaire to determine patient reported symptom measure after each intervention * minimum score: 1, maximum score: 12 * higher score means worse outcome
Compare patient reported symptom measures by IIEF-5 questionnaire after prostatic urethral lift versus TURP1 yearUsing the International index of erectile function- 5 items (IIEF-5) questionnaire to determine patient reported symptom measure after each intervention * minimum score: 1, maximum score: 25 * higher score means better outcome
Compare complication rate of prostatic urethral lift versus TURP in BPH patients with urinary retention5 yearsTo determine the percentage and severity of complications after each intervention (according to the Clavien-Dindo classification)
Compare patient reported quality of life by SF-12 questionnaire after prostatic urethral lift versus TURP1 yearUsing the Short Form 12 (SF-12) questionnaire to determine patient reported quality of life measures after each intervention * minimum score: 0, maximum score: 100 * higher score means better outcome
Compare patient reported quality of life by derived SF-6D utility score after prostatic urethral lift versus TURP1 yearUsing the derived Short Form 6 Dimension (SF-6D) utility score questionnaire to determine patient reported quality of life measures after each intervention * minimum score: 0, maximum score 1.0 * higher score means better outcome
Compare patient reported recovery by VAS after prostatic urethral lift versus TURP1 yearUsing the Visual analogue scale of quality of recovery to determine patient reported recovery after each intervention * minimum score: 0, maximum score 100 * higher score means better outcome
Compare improvement bladder contractility index after prostatic urethral lift versus TURP5 yearPre- and post-intervention urodynamic will be performed to assess bladder contractility index as well as subsequent improvement and durability of above stated urodynamic parameter after each intervention
Compare improvement of Bladder outflow obstruction index after prostatic urethral lift versus TURP5 yearPre- and post-intervention urodynamic will be performed to assess bladder outflow obstruction index (BOOI) as well as subsequent improvement and durability of above stated urodynamic parameter after each intervention
Compare patient reported symptom measures by MSHQ-EjD short form questionnaire after prostatic urethral lift versus TURP1 yearUsing the Male Sexual Health Questionnaire for Ejaculatory Dysfunction (MSHQ-EjD) short form questionnaire to determine patient reported symptom measure after each intervention.

Countries

China

Contacts

Primary ContactBrian SH Ho, MBBS
hobrian@hku.hk(852)2255-3023
Backup ContactStacia Chun, BSc(Hons)
stac@hku.hk(852)2255-4852

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026